Skip to main content
AmigoFish

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.

From U.S. Supreme Court Oral Arguments · · 1 hr 0 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

A case in which the Court held that a generic drug manufacturer does not actively induce patent infringement under 35 U.S.C. §271(b) when its communications consist only of legally required labeling, standard industry language, omissions, and vague statements that lack any affirmative purpose of encouraging the patented use.

Back to U.S. Supreme Court Oral Arguments · Report a problem